The DOI matches its Crossref record; 76 of the 78 references it cites were found in a registry or an index.
Hepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice
Open accessPublished version of a preprint
Abstract
Hepatic uptake and biosynthesis of fatty acids (FA), as well as the partitioning of FA into oxidative, storage, and secretory pathways are tightly regulated processes. Dysregulation of one or more of these processes can promote excess hepatic lipid accumulation, ultimately leading to systemic metabolic dysfunction. Angiopoietin-like-4 (ANGPTL4) is a secretory protein that inhibits lipoprotein lipase (LPL) and modulates triacylglycerol (TAG) homeostasis. To understand the role of ANGPTL4 in liver lipid metabolism under normal and high-fat fed conditions, we generated hepatocyte specific Angptl4 mutant mice (Hmut). Using metabolic turnover studies, we demonstrate that hepatic Angptl4 deficiency facilitates catabolism of TAG-rich lipoprotein (TRL) remnants in the liver via increased hepatic lipase (HL) activity, which results in a significant reduction in circulating TAG and cholesterol levels. Consequently, depletion of hepatocyte Angptl4 protects against diet-induce obesity, glucose intolerance, liver steatosis, and atherogenesis. Mechanistically, we demonstrate that loss of Angptl4 in hepatocytes promotes FA uptake which results in increased FA oxidation, ROS production, and AMPK activation. Finally, we demonstrate the utility of a targeted pharmacologic therapy that specifically inhibits Angptl4 gene expression in the liver and protects against diet-induced obesity, dyslipidemia, glucose intolerance, and liver damage, which likely occurs via increased HL activity. Notably, this novel inhibition strategy does not cause any of the deleterious effects previously observed with neutralizing antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“hepatocyte-specific deletion of ANGPTL4 attenuated obesity, liver steatosis, and atherosclerosis in high-fat-diet mice [32].”
From Identifying novel drug targets for calcific aortic valve disease through Mendelian randomization (2025) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,094
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089
Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, É., Shyy, J. Y.-J., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.009 · Cited by 1,840
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
Regulation of hepatic glucose metabolism in health and disease
Petersen, M. C., Vatner, D. F., & Shulman, G. I. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.80 · Cited by 1,159
Dyslipidemia in type 2 diabetes mellitus
Mooradian, A. D. (2009) · Nature Reviews Endocrinology · doi:10.1038/ncpendmet1066 · Cited by 1,053
The interaction of hepatic lipid and glucose metabolism in liver diseases
Bechmann, L. P., Hannivoort, R. A., Gerken, G., Hotamışlıgil, G. S., Trauner, M., & Canbay, A. E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.025 · Cited by 1,033
Cusi, K. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.003 · Cited by 940
Petersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911
Common variants associated with plasma triglycerides and risk for coronary artery disease
Do, R., Willer, C. J., Schmidt, E. M., Sengupta, S., Gao, C., Peloso, G. M., Gustafsson, S., Kanoni, S., Ganna, A., Chen, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2795 · Cited by 862
AMP-activated protein kinase: the current landscape for drug development
Steinberg, G. R., & Carling, D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0019-2 · Cited by 785
Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease
Softic, S., Cohen, D. E., & Kahn, C. R. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4054-0 · Cited by 709
Endoplasmic reticulum stress, obesity and diabetes
Cnop, M., Foufelle, F., & Velloso, L. A. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.07.010 · Cited by 705
Direct effects of thyroid hormones on hepatic lipid metabolism
Sinha, R. A., Singh, B. K., & Yen, P. M. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.10 · Cited by 689
Genetics of blood lipids among ∼300,000 multi-ethnic participants of the Million Veteran Program
Global Lipids Genetics Consortium, Klarin, D., Myocardial Infarction Genetics (MIGen) Consortium, The Geisinger-Regeneron DiscovEHR Collaboration, Program, T. V. M. V., Damrauer, S. M., Cho, K., Sun, Y. V., Teslovich, T. M., Honerlaw, J., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0222-9 · Cited by 625
Prakash, T. P., Graham, M., Yu, J., Carty, R., Low, A., Chappell, A., Schmidt, K., Zhao, C., Aghajan, M., Murray, H., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku531 · Cited by 588
Exome-wide association study of plasma lipids in >300,000 individuals
Charge Diabetes Working Group, Liu, D. J., The EPIC-InterAct Consortium, EPIC-CVD Consortium, GOLD Consortium, Program, V. M. V., Peloso, G. M., Yu, H., Butterworth, A. S., Wang, X., et al. (2017) · Nature Genetics · doi:10.1038/ng.3977 · Cited by 540
Kersten, S., Mandard, S., Tan, N. S., Escher, P., Metzger, D., Chambon, P., Gonzalez, F. J., Desvergne, B., & Wahli, W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004029200 · Cited by 489
Pike, L. S., Smift, A., Croteau, N. J., Ferrick, D. A., & Wu, M. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.022 · Cited by 482
Fatty acids as modulators of the cellular production of reactive oxygen species
Schönfeld, P., & Wojtczak, L. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.04.029 · Cited by 452
Endoplasmic Reticulum Stress and Inflammation in Obesity and Diabetes
Hummasti, S., & Hotamışlıgil, G. S. (2010) · Circulation Research · doi:10.1161/circresaha.110.225698 · Cited by 445
Mandard, S., Zandbergen, F., van Straten, E., Wahli, W., Kuipers, F., Müller, M., & Kersten, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506519200 · Cited by 433
Köster, A., Chao, Y. B., Mosior, M., Ford, A., Gonzalez-DeWhitt, P. A., Hale, J. E., Li, D., Qiu, Y., Fraser, C. C., Yang, D. D., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0476 · Cited by 427 · cited 1×
“The role of ANGPTL4 in mouse body weight regulation under both physiological and pathophysiological conditions has been controversial (13, 21, 28, 32).”
BackgroundAdiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci
Stender, S., Kozlitina, J., Nordestgaard, B. G., Tybjærg‐Hansen, A., Hobbs, H. H., & Cohen, J. C. (2017) · Nature Genetics · doi:10.1038/ng.3855 · Cited by 421
An Involvement of Oxidative Stress in Endoplasmic Reticulum Stress and Its Associated Diseases
Bhandary, B., Marahatta, A., Kim, H., & Chae, H. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms14010434 · Cited by 418
Interactions between mitochondrial reactive oxygen species and cellular glucose metabolism
Liemburg-Apers, D. C., Willems, P. H. G. M., Koopman, W. J. H., & Grefte, S. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1520-y · Cited by 412
Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD
Garcia, D., Hellberg, K., Chaix, A., Wallace, M., Herzig, S., Badur, M. G., Lin, T. C., Shokhirev, M. N., Pinto, A. F. M., Ross, D. S., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.036 · Cited by 296
Xu, A., Lam, M. C., Chan, K. W., Wang, Y., Zhang, J., Hoo, R. L. C., Xu, J. Y., Chen, B., Chow, W.-S., Tso, A. W. K., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408452102 · Cited by 269
Angiopoietin-like 4: a decade of research
Zhu, P., Goh, Y. Y., Chin, H. F. A., Kersten, S., & Tan, N. S. (2011) · Bioscience Reports · doi:10.1042/bsr20110102 · Cited by 267
Lichtenstein, L., Mattijssen, F., de Wit, N. J., Georgiadi, A., Hooiveld, G. J., van der Meer, R., He, Y., Qi, L., Köster, A., Tamsma, J. T., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.002 · Cited by 251
Obesity and nonalcoholic fatty liver disease: current perspectives
Sarwar, R., Pierce, N., & Koppe, S. (2018) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s146339 · Cited by 242
Ectopic lipid storage and insulin resistance: a harmful relationship
Borén, J., Taskinen, M., Olofsson, S. ‐., & Levin, M. C. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12071 · Cited by 240
ANGPTL4 in Metabolic and Cardiovascular Disease
Aryal, B. K., Price, N. L., Suárez, Y., & Fernandez-Hernando, C. F. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.05.010 · Cited by 239
Self-citationTriglyceride-rich lipoproteins as a causal factor for cardiovascular disease
Toth, P. (2016) · Vascular Health and Risk Management · doi:10.2147/vhrm.s104369 · Cited by 237
Regulation of AMPK Activation by CD36 Links Fatty Acid Uptake to β-Oxidation
Samovski, D., Sun, J., Pietka, T., Gross, R. W., Eckel, R. H., Su, X., Stahl, P. D., & Abumrad, N. A. (2014) · Diabetes · doi:10.2337/db14-0582 · Cited by 218
Self-citationThe Problem of Establishing Relationships between Hepatic Steatosis and Hepatic Insulin Resistance
Farese, R. V., Zechner, R., Newgard, C. B., & Walther, T. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.004 · Cited by 216
Regulation of lipoprotein lipase by Angptl4
Dijk, W., & Kersten, S. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.12.005 · Cited by 207
Interorgan Metabolic Crosstalk in Human Insulin Resistance
Gancheva, S., Jeleník, T., Álvarez-Hernández, E., & Roden, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00015.2017 · Cited by 194
Postprandial lipoprotein metabolism: VLDL vs chylomicrons
Nakajima, K., Nakano, T., Tokita, Y., Nagamine, T., Inazu, A., Kobayashi, J., Mabuchi, H., Stanhope, K. L., Havel, P. J., Okazaki, M., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.04.018 · Cited by 179
AMPK Activation Reduces Hepatic Lipid Content by Increasing Fat Oxidation In Vivo
Foretz, M., Even, P. C., & Viollet, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092826 · Cited by 177
Desai, U., Lee, E.-C., Chung, K., Gao, C., Gay, J., Key, B., Hansen, G., Machajewski, D., Platt, K. A., Sands, A. T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705041104 · Cited by 175
Palmitate-mediated Alterations in the Fatty Acid Metabolism of Rat Neonatal Cardiac Myocytes
Hickson-Bick, D. L. M., Buja, L. M., & McMillin, J. B. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.1098 · Cited by 170
Lichtenstein, L., Berbée, J. F. P., van Dijk, S. J., van Dijk, K. W., Bensadoun, A., Kema, I. P., Voshol, P. J., Müller, M., Rensen, P. C. N., & Kersten, S. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.151894 · Cited by 163
A systems study reveals concurrent activation of AMPK and mTOR by amino acids
Dalle Pezze, P., Ruf, S., Sonntag, A. G., Langelaar-Makkinje, M., Hall, P., Heberle, A. M., Razquin Navas, P., van Eunen, K., Tölle, R. C., Schwarz, J. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms13254 · Cited by 148
Gusarova, V., O’Dushlaine, C., Teslovich, T. M., Benotti, P. N., Mirshahi, T., Gottesman, O., Van Hout, C. V., Murray, M. F., Mahajan, A., Nielsen, J. B., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04611-z · Cited by 145
Hypothalamic Angptl4/Fiaf Is a Novel Regulator of Food Intake and Body Weight
Kim, H.-K., Youn, B., Shin, M.-S., NamKoong, C., Park, K. H., Baik, J., Kim, J. B., Park, J., Lee, K., Kim, Y., et al. (2010) · Diabetes · doi:10.2337/db10-0145 · Cited by 133
Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis
Aryal, B., Singh, A. K., Zhang, X., Varela, L., Rotllan, N., Goedeke, L., Chaube, B., Camporez, J.-P., Vatner, D. F., Horvath, T. L., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.97918 · Cited by 127
Self-citationFatty acids stimulate AMP‐activated protein kinase and enhance fatty acid oxidation in L6 myotubes
Watt, M. J., Steinberg, G. R., Chen, Z., Kemp, B. E., & Febbraio, M. A. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.107318 · Cited by 121
Singh, A. K., Aryal, B., Chaube, B., Rotllan, N., Varela, L., Horvath, T. L., Suárez, Y., & Fernández-Hernando, C. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.03.011 · Cited by 110
Self-citationClark, H. S., Carling, D., & Saggerson, D. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04151.x · Cited by 105
Janssen, A. W. F., Katiraei, S., Bartosinska, B., Eberhard, D., Willems van Dijk, K., & Kersten, S. (2018) · Diabetologia · doi:10.1007/s00125-018-4583-5 · Cited by 96
New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk
Kersten, S. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000600 · Cited by 95
Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutrition
Hu, H., Lee, S., Sousa‐Lima, I., Kim, S. S., Hwang, W. M., Dagon, Y., Yang, W.-M., Cho, S., Kang, M., Seo, J. A., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci63562 · Cited by 95
Aryal, B., Rotllan, N., Araldi, E., Ramírez, C. M., He, S., Chousterman, B. G., Fenn, A. M., Wanschel, A., Madrigal-Matute, J., Warrier, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms12313 · Cited by 93
Self-citationDesign and cloning of lentiviral vectors expressing small interfering RNAs
Tiscórnia, G., Singer, O., & Verma, I. M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.36 · Cited by 92
Shafique, E., Choy, W. C., Liu, Y., Feng, J., Cordeiro, B., Lyra, A., Arafah, M., Yassin-Kassab, A., Zanetti, A. V. D., Clements, R., et al. (2013) · Aging · doi:10.18632/aging.100569 · Cited by 76
Kristensen, K. K., Leth-Espensen, K. Z., Mertens, H. D. T., Birrane, G., Meiyappan, M., Olivecrona, G., Jørgensen, T. J. D., Young, S. G., & Ploug, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920202117 · Cited by 72
Hepatic Catabolism of Remnant Lipoproteins: Where the Action Is
Havel, R. J., & Hamilton, R. L. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000115382.53810.24 · Cited by 59
Hepatic lipase treatment of chylomicron remnants increases exposure of apolipoprotein E.
Brasaemle, D. L., Cornely-Moss, K., & Bensadoun, A. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40737-0 · Cited by 53
Purification of 3-hydroxy-3-methylglutaryl-coenzyme A reductase from rat liver.
Kleinsek, D. A., Ranganathan, S., & Porter, J. W. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.4.1431 · Cited by 52
Hepatic fatty acid synthesis and partitioning: the effect of metabolic and nutritional state
Hodson, L. (2018) · Proceedings of The Nutrition Society · doi:10.1017/s0029665118002653 · Cited by 49
Wang, Y., Liu, L.-M., Li, W., Ye, W., Meng, X., Chen, F., Xiao, Q., Chen, J.-Y., & Zhou, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5637 · Cited by 46
Oteng, A.-B., Ruppert, P. M., Boutens, L., Dijk, W., van Dierendonck, X. M. H., Olivecrona, G., Stienstra, R., & Kersten, S. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m094128 · Cited by 46
Barja-Fernández, S., Moreno‐Navarrete, J. M., Folgueira, C., Xifra, G., Sabater, M., Castelao, C., Fernø, J., Leis, R., Diéguez, C., Casanueva, F. F., et al. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800060 · Cited by 43
Regulation of plasma triglyceride partitioning by adipose-derived ANGPTL4 in mice
Spitler, K. M., Shetty, S. K., Cushing, E. M., Sylvers-Davie, K. L., & Davies, B. S. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-87020-5 · Cited by 42
Human papillomavirus infection and invasive cervical neoplasia: a study of prevalence and morphology
Zehbe, I., & Wilander, E. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199703)181:3 · Cited by 41
Gutgsell, A. R., Ghodge, S. V., Bowers, A. A., & Neher, S. B. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005932 · Cited by 41
Variants inANGPTL4and the Risk of Coronary Artery Disease
Morrison, A. R., Fu, Y., & O’Donnell, C. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1607380 · Cited by 24
ANGPTL-4 is Associated with Obesity and Lipid Profile in Children and Adolescents
Barja-Fernández, S., Folgueira, C., Castelao, C., Pena-León, V., González-Sáenz, P., Vázquez‐Cobela, R., Aguilera, C. M., Gil‐Campos, M., Bueno, G., Gil, Á., et al. (2019) · Nutrients · doi:10.3390/nu11061340 · Cited by 20
Bays, N. W., Hill, A. D., & Kariv, I. (2009) · SLAS DISCOVERY · doi:10.1177/1087057109335746 · Cited by 20
Bailetti, D., Bertoccini, L., Mancina, R. M., Barchetta, I., Capoccia, D., Cossu, E., Pujia, A., Lenzi, A., Leonetti, F., Cavallo, M. G., et al. (2018) · Obesity Science & Practice · doi:10.1002/osp4.311 · Cited by 19
Mouse hepatic lipase alleles with variable effects on lipoprotein composition and size
Pratt, S. M., Chiu, S., Espinal, G. M., Shibata, N. M., Wong, H., & Warden, C. H. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m002378 · Cited by 4
Flagged first, then by citations
2 of the 78 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- 10.1172/JCI22422 · DOI · Paper page
Cited by
Sorted by citations
Addressing dyslipidemic risk beyond LDL-cholesterol
Tall, A. R., Thomas, D. G., Gonzalez-Cabodevilla, A. G., & Goldberg, I. J. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148559 · Cited by 150
Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism
Kersten, S. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100150 · Cited by 151
Ferroptosis Signaling and Regulators in Atherosclerosis
Wang, Y., Zhao, Y., Ye, T., Yang, L. M., Shen, Y., & Li, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.809457 · Cited by 136
Mouse models of atherosclerosis in translational research
Ilyas, I., Little, P. J., Liu, Z., Xu, Y., Kamato, D., Berk, B. C., Weng, J., & Xu, S. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.06.009 · Cited by 124
Triglyceride-rich lipoproteins and cardiovascular diseases
Xu, D., Xie, L., Cheng, C., Xue, F., & Sun, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1409653 · Cited by 73
Metadata
- Authors
- Singh, A. K., Chaube, B., Zhang, X., Sun, J., Citrin, K. M., Canfrán-Duque, A., Aryal, B., Rotllan, N., Varela, L., Lee, R. G., Horvath, T. L., Price, N. L., Suárez, Y., & Fernández-Hernando, C.
- Affiliations
- Yale University (US)
- Ionis Pharmaceuticals (United States) (US)
- Corresponding author
- Suárez, Yajaira
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2021-09-01
- Volume
- 131
- Issue
- 17
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC8409581
- OpenAlex
- W3182800692
- Cited by
- 115
- References
- 78
- Citations by year
- 2026: 12 · 2025: 29 · 2024: 28 · 2023: 16 · 2022: 17 · 2021: 12
- FWCI
- 12.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R35HL135820)
- National Institute of Diabetes and Digestive and Kidney Diseases (5F32DK10348902)
- American Heart Association (16EIA27550005, 20TPA35490202, 17SDG33110002, 20TPA35490416)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- ANGPTL4, hepatocyte-specific knockout, hepatic lipid metabolism, hepatic lipase, lipoprotein lipase, diet-induced obesity, impaired glucose tolerance, hepatic steatosis, atherosclerosis, fatty acid oxidation, AMPK activation, reactive oxygen species, dyslipidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
